Pros | ![]() Among most bought funds within the category. ![]() Beats FD returns for both 3Y & 5Y duration. | ![]() 5Y returns in the top 25% of the category. ![]() 3Y returns in the top 25% of the category. ![]() Among most bought funds within the category. | ||
Cons | - | - |
INDMoney rank | 4/8 | 3/8 | ||
Category,Subcateogry | Equity,Sector - Healthcare | Equity,Sector - Healthcare | ||
Fund Age | 6 Years | 7 Years | ||
Fund Size | 3190 Cr | 6104 Cr | ||
Min Investment | SIP ₹100 Lumpsum ₹100 | SIP ₹100 Lumpsum ₹5000 | ||
Expense Ratio | 0.56% | 1.04% | ||
Exit Load | 0.5% | 1% | ||
Benchmark Index | BSE Healthcare TR INR | BSE Healthcare TR INR |
No of Holdings | 32 | 39 | ||
Top 5 Holdings | Cipla Ltd (8.73%) Sun Pharmaceuticals Industries Ltd (8.22%) Ipca Laboratories Ltd (7.84%) Cohance Lifesciences Ltd (7.79%) Laurus Labs Ltd (6.08%) | Sun Pharmaceuticals Industries Ltd (11.69%) Dr Reddy's Laboratories Ltd (8.85%) Divi's Laboratories Ltd (8.13%) Cipla Ltd (7.54%) Aurobindo Pharma Ltd (5.71%) | ||
No of Sectors | 2 | 3 | ||
Top 3 Sectors | Health (98.51%) Financial Services (1.49%) | Health (96.53%) Basic Materials (2.35%) Financial Services (1.11%) | ||
Equity % | 98.16% | 95.89% | ||
Debt % | - | - | ||
P/E | 40.73 | 32.47 | ||
P/B | 5.29 | 4.4 | ||
Credit Quality | - | - | ||
Modified Duration | - | - | ||
YTM | - | - |
1-Month Return | -0.54% | 0.19% | ||
3-Month Return | 3.82% | 3.31% | ||
6-Month Return | 8.93% | 15.86% | ||
1-Year Return | -0.43% | 4.33% | ||
3-Year Return | 26.36% | 29.38% | ||
5-Year Return | 20.44% | 22.62% |
Sharpe | 1.22 | 1.31 | ||
Alpha | 3.64 | 4.41 | ||
Beta | 0.84 | 0.94 | ||
Standard Deviation | 14.59 | 15.52 | ||
Information Ratio | 0.23 | 1.42 |
Description | DSP Healthcare Fund Direct Growth is an equity fund.The fund could potentially beat inflation in the long-run. | ICICI Prudential Pharma Healthcare and Diagnostics (P.H.D) Fund Direct Growth is an equity fund.The fund could potentially beat inflation in the long-run. | ||
Managers | Chirag Dagli | Dharmesh Kakkad,Sharmila D’mello |